Delivery Order SPE2DB20D3104-SPE2DB24FV5Q3
Award Date 3/19/24
Potential Completion Date 3/20/24
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NESACAINE-MPF 3% VIAL 20ML, a pharmaceutical product, with a ceiling value of $1,618.08 and a period of performance ending on April 1, 2025. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of NESACAINE-MPF 3% VIAL 20ML, a medical product. The contract has a firm fixed price, with a ceiling value of $3,481.05, and a completion date of July 3, 2025. This order is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support...
- This is a $2,931.41 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of NESACAINE-MPF 3% VIAL 20ML, a pharmaceutical product. The award has a completion date of June 10, 2025. This contract is not set-aside and is open to competition. Amerisourcebergen Drug Corp also holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Nesacaine-MPF 3% anesthetic solution in 20 mL vials. The contract has a firm fixed price of $1,215.99 and a completion date of October 15, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide these critical anesthetic products to support military treatment facilities and other federal healthcare providers. The contract is not associated with a...
- The Defense Logistics Agency awarded a $5,475 delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Nesacaine-MPF 3% vials (20 mL) under a firm fixed-price contract structure. The award is non-competitive with no set-aside designation and is scheduled for completion by January 9, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the operating subsidiary of parent company Cencora, Inc., which is a major pharmaceutical distributor...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $281,531.30 and a period of performance through April 24, 2025. AmerisourceBergen will provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications across multiple therapeutic...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, has a ceiling value of $29,247.48 and a completion date of June 17, 2025. AmerisourceBergen Drug Corp is providing a range of pharmaceutical products and medical supplies, including medications across various therapeutic areas such as diabetes,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,942.90 and a period of performance through May 30, 2025. AmerisourceBergen is supplying a range of pharmaceutical products and medical supplies to support military healthcare programs, including medications across multiple therapeutic areas such as diabetes,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide a variety of pharmaceutical and medical products. The contract has a ceiling value of $32,759.22 and a performance period through July 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of various pharmaceutical and medical products. The contract has a ceiling value of $16,203.21 and a period of performance through May 5, 2025. It is a firm-fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...